The FDA has granted the ProSense Cryoablation System marketing authorization for small, low-risk breast cancers in women at least 70 years of age who receive adjuvant endocrine therapy. The ...

WILMINGTON, DE / ACCESSWIRE / March 6, 2023 / Transparency Market Research Inc. - The global Cardiac Cryoablation Device Market is projected to expand at a CAGR of 9.8% from 2023 to 2031, according to ...

IceCure Medical Ltd. announced that the FDA has granted marketing authorization for its ProSense cryoablation system for the ...

A pioneering procedure is showcasing the future of medicine. UC Health performed the region's first fully robotic heart procedure.

May 10, 2004 — Cryoablation for early-stage breast cancer is safe and well tolerated, according to the results of a multi-institutional pilot study published in the May issue of the Annals of Surgical ...

Shanty Gupta feels that cryoablation, a minimally-invasive procedure, is her preferred option, but without coverage, it's ...

Cryoablation may be an effective primary treatment option for women with low-risk breast cancer, according to preliminary findings from the Ice 3 trial. “If the positive preliminary findings are ...

While offering advantages like faster recovery and high patient satisfaction, cryoablation for the treatment of early-stage breast cancer is still under investigation for effectiveness and requires ...

Shares of IceCure Medical (ICCM) went as high as $1.4 on Friday afternoon before paring back gains after the U.S. Food and Drug Administration granted marketing authorization for ProSense, a minimally ...

IceCure Medical Ltd ICCM recently announced that it has received marketing authorization from the FDA for its next-generation single probe cryoablation system, XSense Cryoablation System with ...

ORLANDO -- Cryoablation without excision for low-risk, early-stage breast cancer may be an option for women over 60, 5-year follow-up results from the ICE3 trial showed. At a mean follow-up of 54.2 ...

NET of the lung: The experience of the Italian registry. Clinical features in surgically treated patients with small cell lung cancer: Risk of brain metastasis and possible role of prophylactic ...